Quorum Sensing Regulates ‘swim-or-stick’ Lifestyle in the PhycosphereCong Fei, Shady A. Amin|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 6
Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.Jian Li, Lin Shen, Ying Yuan et al.|Journal of Clinical Oncology|2022Cited by 5
Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).Feng Zhang, Shukui Qin, Yuxian Bai et al.|Journal of Clinical Oncology|2022Cited by 4
Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.Jian Li, Lin Shen, Ye Xu et al.|Journal of Clinical Oncology|2022Cited by 2